BackgroundIt has been reported that management of cardiovascular (CV) risk factors is suboptimal in patients with rheumatoid arthritis (RA). Whether this also applies to psoriatic arthritis (PsA) or ankylosing spondylitis (AS) patients is unknown.ObjectivesThe main objective of this study was to compare control of CV risk factors among disease groups.MethodsInformation on CV risk factors was collected in consecutive adult patients from rheumatology clinic, with RA, PsA or AS. Hypertension (HTN) was defined as systolic blood pressure (BP) ≥140 mmHg, diastolic BP ≥ 90 mmHg and/or antihypertensive treatment, hypercholesterolemia as LDL-cholesterol ≥ 100 mg/L and/or lipid-lowering treatment. Treatment goals were defined according to European Society of Cardiology and EULAR guidelines.ResultsWe included 520 patients (54% women; 46% RA, 22% PsA, 32% AS). Mean age and disease duration were 52.1±14.1 and 11.0±10.6 years, respectively. Out of 520 patients, 203 (39%) had HTN, among whom 140 (69%) were treated and 86 (42%) were controlled; 293 (56%) had HC, among whom 88 (30%) were treated and 51 (17%) were controlled; 30 (6%) had type 2 diabetes, among whom 18 (60%) were controlled. Current smoking was present in 100 patients (19%), obesity in 136 patients (26%) and increased waist circumference in 192 patients (37%).Compared to RA patients, patients with spondyloarthropathies were less often in remission (40% vs. 54%, p<0.005). Furthermore, patients with spondyloarthropathies differed from RA patients by a lower proportion of treated (56% vs. 84%, p<0.001) and treated-to-target (24% vs. 64% p<0.001) HTN, a higher proportion of active smokers (28% vs. 12%, p<0.01), and lower physical activity (29% vs. 46%, p<0.001). Control of LDL-cholesterol was poor in both groups (17% vs.18%, p=0.95). No significant difference between groups was found for diabetes, overweight and obesity.ConclusionCompared to patients with RA, patients with spondyloarthropathies were less well controlled both for disease activity and CV risk factors. Furthermore, lipid control was poor in both groups. If confirmed in a multicentre cohort, these results may help orienting CV prevention strategies and increasing awareness both in physicians and patients, with emphasis on spondyloarthropathies.Reference[1]Agca R et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76(1):17-28.Acknowledgements:NIL.Disclosure of InterestsNone Declared.